Aging Strategy in Healthcare Stocks
By Michael Hodin
Acquisitions in the healthcare and pharmaceuticals sectors are all the rage these days. Among the crop of deals, one of the most interesting and revealing is Abbvie’s recent $21 billion purchase of Pharmacyclics. This deal…